nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.522	1	CbGbCtD
Tenofovir—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.029	0.155	CbGpPWpGaD
Tenofovir—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.0201	0.107	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—ASNA1—amyotrophic lateral sclerosis	0.0166	1	CrCbGaD
Tenofovir—NME1—Synthesis and interconversion of nucleotide di- and triphosphates—GSR—amyotrophic lateral sclerosis	0.0153	0.0813	CbGpPWpGaD
Tenofovir—NME2—hindbrain—amyotrophic lateral sclerosis	0.0127	0.118	CbGeAlD
Tenofovir—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00907	0.0546	CcSEcCtD
Tenofovir—AK2—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00898	0.0479	CbGpPWpGaD
Tenofovir—NME2—embryo—amyotrophic lateral sclerosis	0.00792	0.0735	CbGeAlD
Tenofovir—NME2—brainstem—amyotrophic lateral sclerosis	0.00726	0.0674	CbGeAlD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—RAB5A—amyotrophic lateral sclerosis	0.00672	0.0358	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00623	0.0332	CbGpPWpGaD
Tenofovir—AK4—medulla oblongata—amyotrophic lateral sclerosis	0.00518	0.0481	CbGeAlD
Tenofovir—AK2—cerebellum—amyotrophic lateral sclerosis	0.00495	0.046	CbGeAlD
Tenofovir—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00486	0.0292	CcSEcCtD
Tenofovir—NME1—Nucleotide metabolism—GSR—amyotrophic lateral sclerosis	0.00472	0.0251	CbGpPWpGaD
Tenofovir—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0283	CcSEcCtD
Tenofovir—AK4—spinal cord—amyotrophic lateral sclerosis	0.00462	0.0429	CbGeAlD
Tenofovir—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0272	CcSEcCtD
Tenofovir—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00417	0.0251	CcSEcCtD
Tenofovir—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00414	0.0249	CcSEcCtD
Tenofovir—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00411	0.0247	CcSEcCtD
Tenofovir—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00411	0.0247	CcSEcCtD
Tenofovir—Depression—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0247	CcSEcCtD
Tenofovir—NME1—nervous system—amyotrophic lateral sclerosis	0.00404	0.0375	CbGeAlD
Tenofovir—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0242	CcSEcCtD
Tenofovir—AK2—brain—amyotrophic lateral sclerosis	0.00402	0.0373	CbGeAlD
Tenofovir—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00394	0.0237	CcSEcCtD
Tenofovir—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00392	0.0236	CcSEcCtD
Tenofovir—AK4—nervous system—amyotrophic lateral sclerosis	0.00389	0.0361	CbGeAlD
Tenofovir—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0234	CcSEcCtD
Tenofovir—NME1—central nervous system—amyotrophic lateral sclerosis	0.00389	0.0361	CbGeAlD
Tenofovir—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00386	0.0232	CcSEcCtD
Tenofovir—NME2—nervous system—amyotrophic lateral sclerosis	0.0038	0.0353	CbGeAlD
Tenofovir—NME1—cerebellum—amyotrophic lateral sclerosis	0.0038	0.0353	CbGeAlD
Tenofovir—AK4—central nervous system—amyotrophic lateral sclerosis	0.00375	0.0348	CbGeAlD
Tenofovir—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00369	0.0222	CcSEcCtD
Tenofovir—AK4—cerebellum—amyotrophic lateral sclerosis	0.00366	0.034	CbGeAlD
Tenofovir—NME2—central nervous system—amyotrophic lateral sclerosis	0.00366	0.034	CbGeAlD
Tenofovir—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0219	CcSEcCtD
Tenofovir—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00363	0.0218	CcSEcCtD
Tenofovir—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0218	CcSEcCtD
Tenofovir—NME2—cerebellum—amyotrophic lateral sclerosis	0.00358	0.0332	CbGeAlD
Tenofovir—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0201	CcSEcCtD
Tenofovir—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00333	0.02	CcSEcCtD
Tenofovir—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0195	CcSEcCtD
Tenofovir—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0193	CcSEcCtD
Tenofovir—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00317	0.019	CcSEcCtD
Tenofovir—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00311	0.0187	CcSEcCtD
Tenofovir—NME1—brain—amyotrophic lateral sclerosis	0.00309	0.0287	CbGeAlD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00301	0.016	CbGpPWpGaD
Tenofovir—AK4—brain—amyotrophic lateral sclerosis	0.00298	0.0276	CbGeAlD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—amyotrophic lateral sclerosis	0.00296	0.0158	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00294	0.0157	CbGpPWpGaD
Tenofovir—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00294	0.0177	CcSEcCtD
Tenofovir—NME2—brain—amyotrophic lateral sclerosis	0.00291	0.027	CbGeAlD
Tenofovir—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0165	CcSEcCtD
Tenofovir—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0165	CcSEcCtD
Tenofovir—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0165	CcSEcCtD
Tenofovir—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0164	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00272	0.0163	CcSEcCtD
Tenofovir—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0155	CcSEcCtD
Tenofovir—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0153	CcSEcCtD
Tenofovir—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00254	0.0153	CcSEcCtD
Tenofovir—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0025	0.015	CcSEcCtD
Tenofovir—ABCC10—medulla oblongata—amyotrophic lateral sclerosis	0.00246	0.0228	CbGeAlD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00239	0.0128	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00239	0.0144	CcSEcCtD
Tenofovir—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00237	0.0143	CcSEcCtD
Tenofovir—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00234	0.0141	CcSEcCtD
Tenofovir—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0139	CcSEcCtD
Tenofovir—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0137	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0136	CcSEcCtD
Tenofovir—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0136	CcSEcCtD
Tenofovir—Pain—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0135	CcSEcCtD
Tenofovir—ABCC10—spinal cord—amyotrophic lateral sclerosis	0.00219	0.0203	CbGeAlD
Tenofovir—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00214	0.0129	CcSEcCtD
Tenofovir—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00207	0.0125	CcSEcCtD
Tenofovir—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00207	0.0125	CcSEcCtD
Tenofovir—SLC22A6—brain—amyotrophic lateral sclerosis	0.00194	0.018	CbGeAlD
Tenofovir—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0116	CcSEcCtD
Tenofovir—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0113	CcSEcCtD
Tenofovir—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0112	CcSEcCtD
Tenofovir—ABCC4—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.0018	0.00958	CbGpPWpGaD
Tenofovir—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0108	CcSEcCtD
Tenofovir—ABCC10—cerebellum—amyotrophic lateral sclerosis	0.00174	0.0161	CbGeAlD
Tenofovir—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00173	0.0104	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.00171	0.00913	CbGpPWpGaD
Tenofovir—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00167	0.01	CcSEcCtD
Tenofovir—Rash—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00995	CcSEcCtD
Tenofovir—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00994	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00165	0.00878	CbGpPWpGaD
Tenofovir—Headache—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00988	CcSEcCtD
Tenofovir—ABCC4—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.00162	0.00863	CbGpPWpGaD
Tenofovir—AK2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00161	0.0086	CbGpPWpGaD
Tenofovir—AK2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00161	0.0086	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.0016	0.00852	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00157	0.00838	CbGpPWpGaD
Tenofovir—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00937	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.00154	0.00822	CbGpPWpGaD
Tenofovir—ABCC4—nervous system—amyotrophic lateral sclerosis	0.00153	0.0142	CbGeAlD
Tenofovir—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.00152	0.0141	CbGeAlD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.0015	0.00801	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—amyotrophic lateral sclerosis	0.00148	0.00787	CbGpPWpGaD
Tenofovir—AK2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00148	0.00787	CbGpPWpGaD
Tenofovir—ABCC4—central nervous system—amyotrophic lateral sclerosis	0.00147	0.0137	CbGeAlD
Tenofovir—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00146	0.0136	CbGeAlD
Tenofovir—ABCC10—brain—amyotrophic lateral sclerosis	0.00141	0.0131	CbGeAlD
Tenofovir—ABCC10—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00141	0.00752	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00137	0.00731	CbGpPWpGaD
Tenofovir—AK2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00129	0.00688	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.00124	0.00659	CbGpPWpGaD
Tenofovir—ABCC4—brain—amyotrophic lateral sclerosis	0.00117	0.0109	CbGeAlD
Tenofovir—AK2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00117	0.00622	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00116	0.00619	CbGpPWpGaD
Tenofovir—SLC22A8—brain—amyotrophic lateral sclerosis	0.00116	0.0108	CbGeAlD
Tenofovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00113	0.00604	CbGpPWpGaD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00113	0.00601	CbGpPWpGaD
Tenofovir—NME2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00112	0.00596	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00112	0.00596	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00107	0.0057	CbGpPWpGaD
Tenofovir—NME2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00102	0.00545	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000979	0.00522	CbGpPWpGaD
Tenofovir—NME2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000951	0.00507	CbGpPWpGaD
Tenofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000945	0.00504	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.000937	0.00499	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000935	0.00498	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000909	0.00484	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000902	0.00481	CbGpPWpGaD
Tenofovir—NME2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000894	0.00477	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000884	0.00471	CbGpPWpGaD
Tenofovir—NME1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000848	0.00452	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000848	0.00452	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.000839	0.00447	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000816	0.00435	CbGpPWpGaD
Tenofovir—NME2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000809	0.00431	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000798	0.00425	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000783	0.00417	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000783	0.00417	CbGpPWpGaD
Tenofovir—NME1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000775	0.00413	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000773	0.00412	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000773	0.00412	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000746	0.00397	CbGpPWpGaD
Tenofovir—NME1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000721	0.00384	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000718	0.00383	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000689	0.00367	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000679	0.00362	CbGpPWpGaD
Tenofovir—NME1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000678	0.00361	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00067	0.00357	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00066	0.00352	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.000636	0.00339	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000636	0.00339	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000613	0.00327	CbGpPWpGaD
Tenofovir—NME1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000613	0.00327	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000604	0.00322	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000593	0.00316	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000578	0.00308	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000567	0.00302	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000566	0.00301	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000536	0.00285	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000527	0.00281	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000515	0.00274	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000514	0.00274	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000509	0.00271	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000489	0.00261	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000482	0.00257	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000478	0.00255	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	0.000477	0.00254	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000472	0.00252	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000465	0.00248	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000465	0.00248	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	0.000455	0.00242	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000447	0.00238	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000433	0.00231	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00043	0.00229	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000429	0.00228	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000415	0.00221	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000412	0.00219	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000411	0.00219	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000398	0.00212	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000382	0.00204	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00037	0.00197	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00036	0.00192	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000352	0.00188	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000347	0.00185	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000345	0.00184	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000331	0.00176	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000331	0.00176	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000324	0.00172	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000314	0.00167	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	0.000312	0.00166	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000311	0.00166	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	0.000297	0.00158	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000293	0.00156	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000293	0.00156	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000293	0.00156	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000288	0.00154	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000281	0.0015	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000281	0.0015	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000279	0.00149	CbGpPWpGaD
Tenofovir—AK2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000272	0.00145	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000262	0.00139	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000251	0.00134	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00025	0.00133	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000245	0.00131	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000245	0.00131	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000237	0.00126	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000237	0.00126	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000229	0.00122	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000226	0.0012	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000224	0.00119	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000218	0.00116	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000212	0.00113	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000211	0.00113	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000206	0.0011	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000195	0.00104	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000192	0.00102	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000189	0.00101	CbGpPWpGaD
Tenofovir—NME2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000189	0.00101	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000187	0.000994	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000182	0.000972	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00018	0.000961	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000179	0.000954	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000174	0.000927	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000161	0.000855	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000154	0.000819	CbGpPWpGaD
Tenofovir—NME1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000143	0.000762	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000138	0.000737	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000699	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000129	0.000689	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000129	0.000689	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000124	0.000659	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000109	0.000582	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0001	0.000535	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0001	0.000535	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.8e-05	0.000522	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.37e-05	0.000499	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	9.19e-05	0.00049	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.54e-05	0.000455	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	8.03e-05	0.000428	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	7.26e-05	0.000387	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.13e-05	0.00038	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	5.5e-05	0.000293	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—amyotrophic lateral sclerosis	5.39e-05	0.000287	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	5.08e-05	0.000271	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.63e-05	0.000246	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	4.17e-05	0.000222	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.81e-05	0.000203	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.61e-05	0.000139	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.24e-05	0.000119	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.06e-05	0.00011	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.69e-05	9.03e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-05	6.19e-05	CbGpPWpGaD
